Marc Tischkowitz

Citée par

	Toutes	Depuis 2019
Citations	32887	20038
indice h	87	67
indice i10	235	195

4200

2100

1050

3150

200420052006200720082009201020112012201320142015201620172018201920202021202220232024132 138 234 260 372 403 472 542 691 822 1043 1308 1683 1849 2363 2842 3452 4187 4106 4018 1383

Accès public

Tout afficher

226 articles

14 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

William D. FoulkesProfessor of Oncology, Medicine, and Human Genetics. McGill UniversityAdresse e-mail validée de mail.mcgill.ca
Douglas EastonProfessor of Genetic Epidemiology, University of CambridgeAdresse e-mail validée de medschl.cam.ac.uk
Paul PharoahUniversity of CambridgeAdresse e-mail validée de medschl.cam.ac.uk
Evans DG*, Evans G*University of ManchesterAdresse e-mail validée de mft.nhs.uk
David HuntsmanBC Cancer AgencyAdresse e-mail validée de bccancer.bc.ca
Clare TurnbullProfessor of Translational Cancer Genetics, Institute of Cancer ResearchAdresse e-mail validée de icr.ac.uk
Fiona WalterQueen Mary University of LondonAdresse e-mail validée de qmul.ac.uk
Mark E. RobsonMemorial Sloan KetteringAdresse e-mail validée de mskcc.org
Sean TavtigianProfessor of Oncological Science, University of UtahAdresse e-mail validée de hci.utah.edu
Melissa C SoutheyChair Precision Medicine, Monash UniversityAdresse e-mail validée de monash.edu
Peter DevileeLeiden University Medical CenterAdresse e-mail validée de lumc.nl
Steven NarodCanada Research Chair in Breast Cancer; Director, Familial Breast Cancer Research Unit, WCRIAdresse e-mail validée de wchospital.ca
Emma R. WoodwardManchester Centre for Genomic MedicineAdresse e-mail validée de mft.nhs.uk
Georgia Chenevix-TrenchQueensland Institute of Medical ResearchAdresse e-mail validée de qimr.edu.au
Katherine L NathansonProfessor of Medicine, Perelman School of Medicine at the University of PennsylvaniaAdresse e-mail validée de upenn.edu
Chantal Babb de VilliersUniversity of CambridgeAdresse e-mail validée de medschl.cam.ac.uk
Marjanka K SchmidtNetherlands Cancer InstituteAdresse e-mail validée de nki.nl
Helmut Hanenberg, MDUniversity Children's Hospital, University of Duisburg-EssenAdresse e-mail validée de uni-due.de
Patrick ConcannonDepartment of Pathology, Immunology, and Laboratory Medicine, University of FloridaAdresse e-mail validée de ufl.edu
Massimiliano di PietroClinician Scientist, Early Cancer Institute, University of CambridgeAdresse e-mail validée de cam.ac.uk

Suivre

Marc Tischkowitz

University of Cambridge

Adresse e-mail validée de cam.ac.uk - Page d'accueil

Cancer Genetics DNA repair Cancer Syndromes


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ... Jama 317 (23), 2402-2416, 2017	2692	2017
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non … KA Gelmon, M Tischkowitz, H Mackay, K Swenerton, A Robidoux, ... The lancet oncology 12 (9), 852-861, 2011	1326	2011
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE N Mavaddat, S Peock, D Frost, S Ellis, R Platte, E Fineberg, DG Evans, ... JNCI: Journal of the National Cancer Institute 105 (11), 812-822, 2013	1080	2013
Breast-Cancer Risk in Families with Mutations in PALB2 AC Antoniou, S Casadei, T Heikkinen, D Barrowdale, K Pylkäs, J Roberts, ... New England Journal of Medicine 371 (6), 497-506, 2014	1070	2014
Gene-panel sequencing and the prediction of breast-cancer risk DF Easton, PDP Pharoah, AC Antoniou, M Tischkowitz, SV Tavtigian, ... New England Journal of Medicine 372 (23), 2243-2257, 2015	1015	2015
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer E Castro, C Goh, D Olmos, E Saunders, D Leongamornlert, ... Journal of Clinical Oncology 31 (14), 1748, 2013	887	2013
Prevalence and architecture of de novo mutations in developmental disorders Nature 542 (7642), 433-438, 2017	880	2017
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer S Reid, D Schindler, H Hanenberg, K Barker, S Hanks, R Kalb, ... Nature genetics 39 (2), 162-164, 2007	724	2007
Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors T Taniguchi, M Tischkowitz, N Ameziane, SV Hodgson, CG Mathew, ... Nature medicine 9 (5), 568-574, 2003	708	2003
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers RS van der Post, IP Vogelaar, F Carneiro, P Guilford, D Huntsman, ... Journal of medical genetics 52 (6), 361-374, 2015	635	2015
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors A Lee, N Mavaddat, AN Wilcox, AP Cunningham, T Carver, S Hartley, ... Genetics in medicine 21 (8), 1708-1718, 2019	563	2019
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer M Tischkowitz, JS Brunet, LR Bégin, DG Huntsman, MCU Cheang, ... BMC cancer 7, 1-11, 2007	562	2007
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015	547	2015
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer P Kaurah, A MacMillan, N Boyd, J Senz, A De Luca, N Chun, G Suriano, ... Jama 297 (21), 2360-2372, 2007	524	2007
Hereditary breast cancer: new genetic developments, new therapeutic avenues PM Campeau, WD Foulkes, MD Tischkowitz Human genetics 124, 31-42, 2008	500	2008
Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type L Witkowski, J Carrot-Zhang, S Albrecht, S Fahiminiya, N Hamel, ... Nature genetics 46 (5), 438-443, 2014	459	2014
Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease KJ Carss, G Arno, M Erwood, J Stephens, A Sanchis-Juan, S Hull, K Megy, ... The American Journal of Human Genetics 100 (1), 75-90, 2017	409	2017
Fanconi anaemia MD Tischkowitz, SV Hodgson Journal of medical genetics 40 (1), 1-10, 2003	404	2003
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017	392	2017
Effect of BRCA mutations on metastatic relapse and cause-specific survival after radical treatment for localised prostate cancer E Castro, C Goh, D Leongamornlert, E Saunders, M Tymrakiewicz, ... European urology 68 (2), 186-193, 2015	367	2015

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs